Chronic Lymphocytic Leukemia Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Collaborating with Your Nurse Practitioner
A healthy relationship between a chronic lymphocytic leukemia (CLL) patient and their healthcare team can help ensure that they receive the best care possible. A key member of that team is a nurse pra... Author: patientpower Added: 05/31/2014 (Source: Oncology Tube)
Source: Oncology Tube - May 31, 2014 Category: Cancer & Oncology Source Type: podcasts

Routine Genetic Profiles and Testing for CLL
Chronic lymphocytic leukemia (CLL) experts, Dr. Januario Castro and Dr. Michael Keating, describe genetic profiling and sequencing and how this affects the future of treatment in CLL. Get email ale... Author: patientpower Added: 05/31/2014 (Source: Oncology Tube)
Source: Oncology Tube - May 31, 2014 Category: Cancer & Oncology Source Type: podcasts

Staying Consistent with Oral CLL Treatment
Now that an oral medication has been approved for chronic lymphocytic leukemia (CLL), patients are tasked with a new responsibility: staying on schedule with their medications, in their own home. An a... Author: patientpower Added: 05/29/2014 (Source: Oncology Tube)
Source: Oncology Tube - May 30, 2014 Category: Cancer & Oncology Source Type: podcasts

Advances in Treating the Full Spectrum of CLL Patients
2014 has been described by many chronic lymphocytic leukemia (CLL) experts as a pivotal year for developing research and treatment. But are effective therapies in development to treat the full CLL spe... Author: patientpower Added: 05/22/2014 (Source: Oncology Tube)
Source: Oncology Tube - May 23, 2014 Category: Cancer & Oncology Source Type: podcasts

What Role Do Prognostic Factors Play in Treating CLL?
Prognostic factors can help establish a patient's chronic lymphocytic leukemia (CLL) prognosis and aid in determining how they will respond to CLL treatment. These factors have more recently assisted ... Author: patientpower Added: 05/22/2014 (Source: Oncology Tube)
Source: Oncology Tube - May 23, 2014 Category: Cancer & Oncology Source Type: podcasts

Coping with the Emotional Aspects of Watch and Wait
For people with chronic lymphocytic leukemia (CLL), the decision to treat typically follows a "Watch and Wait" period that can be unnerving for many patients. Dr. Javier Pinilla-Ibarz, a lea... Author: patientpower Added: 05/16/2014 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2014 Category: Cancer & Oncology Source Type: podcasts

Is It the Era of CLL Research?
There has been growing excitement around chronic lymphocytic leukemia (CLL) research over the last few years, as advances in CLL treatment and disease understanding continue to progress quickly. So wh... Author: patientpower Added: 05/08/2014 (Source: Oncology Tube)
Source: Oncology Tube - May 9, 2014 Category: Cancer & Oncology Source Type: podcasts

Expert Perspectives: Lung Cancer
Cutting-edge updates and expert perspectives on the diagnosis and management of hematologic malignancies, including multiple myeloma, chronic lymphocytic leukemia and related disorders, and Hodgkin's ... Author: imedex Added: 04/16/2014 (Source: Oncology Tube)
Source: Oncology Tube - April 16, 2014 Category: Cancer & Oncology Source Type: podcasts

The Role of Genetic Profiling When Choosing CLL Treatment
With so many new treatment options for chronic lymphocytic leukemia (CLL), how do you choose a treatment that's right for you? Dr. Januario Castro of UC San Diego Moores Cancer Center explores how gen... Author: patientpower Added: 04/02/2014 (Source: Oncology Tube)
Source: Oncology Tube - April 3, 2014 Category: Cancer & Oncology Source Type: podcasts

Idelalisib: new targeted therapy improves outlook for patients with chronic lymphocytic leukaemia
NEW ORLEANS—A new oral tyrosine kinase inhibitor drug — idelalisib — has proved effective — and to have low toxicity — in patients with chronic lymphocytic leukaemia (CLL). Richard Furman MD from We... Author: AudioMedica Added: 03/12/2014 (Source: Oncology Tube)
Source: Oncology Tube - March 12, 2014 Category: Cancer & Oncology Source Type: podcasts

FDA Sends Valentine to CLL Patients
The FDA approval of ibrutinib is a red-letter day for patients with relapsed chronic lymphocytic leukemia, because of the drug’s quick action and effectiveness, says Dr. Bruce Cheson. (Source: Medscape Oncology)
Source: Medscape Oncology - February 14, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts